Penumbra PEN
NYSE PEN
$317.57 -0.47 (-0.15%)
At close: Oct 2, 2026 · 4:00 PM EDT

Penumbra (PEN) Gains from Sales and Divestitures (2014 - 2016)

Updated

Penumbra's Gains from Sales and Divestitures was -$84,000 in Q4 2016, compared with -$31,000 a year earlier.

Analysis

Penumbra (PEN) Gains from Sales and Divestitures (2014 - 2016) Analysis & Trends

For FY2016, Gains from Sales and Divestitures at Penumbra came in at -$143,000.

  • In earlier years, Gains from Sales and Divestitures was -$43,000 in FY2015, -$21,000 in FY2014 and -$3,000 in FY2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn
10 Penumbra 12.51 Bn 10.22 Bn 264.94 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 -84,000.00
Jun 30, 2016 -48,000.00
Mar 31, 2016 -11,000.00
Dec 31, 2015 -31,000.00
Jun 30, 2015 -12,000.00
Dec 31, 2014 9,000.00
API Access

Penumbra Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=PEN&period=max&api_key=YOUR_API_KEY